Discovery of novel NO-releasing celastrol derivatives with Hsp90 inhibition and cytotoxic activities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of novel NO-releasing celastrol derivatives with Hsp90 inhibition and cytotoxic activities

Published:2018-12 Issue: Volume:160 Page:1-8
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Li Na,Xu Manyi,Bao Na,Shi Wei,Li Qixing,Zhang Xiaowei,Sun Jianbo,Chen Li^ORCID

Funder

Academic Innovation Project of Jiangsu Department of Education

College Students Innovation Project for the R&D of Novel Drugs

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference37 articles.

1. Celastrol: Molecular targets of Thunder God Vine

2. Design, synthesis and biological evaluation of novel C-29 carbamate celastrol derivatives as potent and selective cytotoxic compounds

3. Design and synthesis of celastrol derivatives as anticancer agents

4. Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction

5. A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scaffold hopping of celastrol provides derivatives containing pepper ring, pyrazine and oxazole substructures as potent autophagy inducers against breast cancer cell line MCF-7;European Journal of Medicinal Chemistry;2022-04

2. Design, synthesis and biological activity evaluation of novel scopoletin-NO donor derivatives against MCF-7 human breast cancer in vitro and in vivo;European Journal of Medicinal Chemistry;2021-11

3. Self-Assembly Dual-Responsive NO Donor Nanoparticles for Effective Cancer Therapy;ACS Applied Materials & Interfaces;2021-10-20

4. Nitric oxide-donating and reactive oxygen species-responsive prochelators based on 8-hydroxyquinoline as anticancer agents;European Journal of Medicinal Chemistry;2021-02

5. Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application;Frontiers in Pharmacology;2020-11-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3